Lead Product(s): DARPin
Therapeutic Area: Infections and Infectious Diseases
Highest Development Status: Preclinical Product Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 20, 2020
Molecular Partners has identified multiple potent monospecific DARPin® proteins which neutralize samples of the SARS-CoV-2 virus.